Abstract

Microbial contamination poses a significant risk to pharmaceutical manufacturing processes, potentially compromising product quality, safety, and efficacy. This article examines the challenges posed by microbial contamination in pharmaceutical manufacturing and explores strategies and best practices for effective control. Key topics include the sources and risks of microbial contamination, regulatory standards, challenges in contamination control, and strategies such as good manufacturing practices, environmental monitoring, sterilization, personnel hygiene, and supplier audits. By implementing proactive measures and adhering to regulatory guidelines, pharmaceutical companies can mitigate the risk of contamination and ensure the integrity of their products